Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Virtual Biopsy

Medicine

Last year, doctors told 1.3 million patients in the United States that they had skin cancer. But still more people underwent painful biopsies-in which a suspect mole is cut off, sliced into thin sections and examined under a microscope-on what turned out to be healthy skin. A new laser-based imaging device could allow doctors to peer painlessly into the skin and diagnose growths without surgical biopsies.

The device is a descendant of a laboratory tool called the confocal microscope. By scanning a laser beam across a tissue sample and detecting the light reflected back, the desk-sized microscope can piece together highly detailed images of successive layers of cells, creating virtual slices through the tissue. Lucid in Rochester, NY, and Optiscan Imaging in Notting Hill, Australia, are adapting the microscope to the doctor’s office. Ashfaq Marghoob, a dermatologist at Memorial Sloan-Kettering Cancer Center in New York who is testing Lucid’s “VivaScope,” is enthusiastic about the technology. “Instead of cutting out hundreds of moles, you can just scan them and follow any changes over time,” Marghoob says.

Preliminary studies indicate that devices like the VivaScope and Optiscan’s Stratum may be as reliable as standard biopsies in diagnosing many forms of skin cancer. Lucid senior vice president Stuart Itkin says the company aims to have a commercial model ready by May; Optiscan is planning to begin U.S. clinical trials around January. Itkin says confocal microscopy could be used to detect other cancers as well, replacing Pap smears and cervix and mouth biopsies.

This story is part of our September 2001 Issue
See the rest of the issue
Subscribe

Getting doctors to accept the new tool will be key to realizing that vision, though. That’s why Harvard Medical School pathologist Martin Mihm, a consultant for Lucid, is developing software to make the microscope’s images look more like biopsy slides. “If it’s not familiar to pathologists, [it’s] more difficult to use,” Mihm says. But if the device developers can make the diagnostic tool simple and accurate enough, millions of anxious patients will have one less thing to fear.

Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.

Subscribe today
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.